Fidelity National Financial (FNF)
(Delayed Data from NYSE)
$60.23 USD
+1.11 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $60.26 +0.03 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.23 USD
+1.11 (1.88%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $60.26 +0.03 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Zacks News
FNF Group (FNF) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, FNF Group (FNF) closed at $39.88, marking a +0.15% move from the previous day.
Down 20.3% in 4 Weeks, Here's Why FNF Group (FNF) Looks Ripe for a Turnaround
by Zacks Equity Research
FNF Group (FNF) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
FNF Group (FNF) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, FNF Group (FNF) closed at $40.96, marking a +0.32% move from the previous day.
Should Value Investors Buy Fidelity National Financial (FNF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FNF Group (FNF) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, FNF Group (FNF) closed at $42.57, marking a +1.38% move from the previous day.
Reasons to Add Fidelity National (FNF) Stock to Your Kitty
by Zacks Equity Research
Fidelity National (FNF), having a leading market share in the residential purchase, refinance, and commercial markets, is poised to benefit from an improving U.S. real estate market.
Reasons Why You Should Hold Reinsurance Group (RGA) Stock
by Zacks Equity Research
Reinsurance Group (RGA) is poised to benefit from higher business volume, favorable longevity experience as well as effective capital deployment.
Best Value Stocks to Buy for April 19th
by Zacks Equity Research
CLF, FNF, and WSM made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 19, 2022.
New Strong Buy Stocks for April 19th
by Zacks Equity Research
have been added to the Zacks Rank #1 (Strong Buy) List on April 19, 2022.
Best Income Stocks to Buy for April 19th
by Zacks Equity Research
GRIN, BHP, and FNF made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 19, 2022.
MetLife's (MET) Arm MIM Closes $1.6B Private Equity Fund
by Zacks Equity Research
MetLife's (MET) business MIM used the secondaries market for third-party equity fund. The portfolio includes 80 fund positions across various sectors.
Chubb (CB) Rallies 31% in a Year: Will the Bull Run Continue?
by Zacks Equity Research
A compelling portfolio, strong renewal retentions, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
Reasons Why Investors Should Hold Sun Life Financial (SLF)
by Zacks Equity Research
Sun Life Financial (SLF) is well-poised to gain from higher individual life insurance sales, higher real estate valuations and sufficient liquidity.
MetLife (MET) Arm Gets CBI License to Aid European Investors
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM receives a CBI authorization, which in turn, will help it deliver sound investment capabilities and benefit investors in the EEA.
Should You Retain Progressive (PGR) Stock in Your Portfolio?
by Zacks Equity Research
Progressive (PGR) is poised to grow given its solid segmental performance, underwriting profitability and sufficient liquidity.
Why Should You Hold Radian Group (RDN) in Your Portfolio?
by Zacks Equity Research
Radian Group (RDN) is poised to grow due to growth in the purchase market, an increase in closed orders in the title services business and sufficient liquidity.
New Strong Buy Stocks for April 12th
by Zacks Equity Research
KOS, FNF, GRIN, SM, and PTR have been added to the Zacks Rank #1 (Strong Buy) List on April 12th, 2022.
Best Value Stocks to Buy for April 12th
by Zacks Equity Research
YPF, FNF, and SM made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 12, 2022.
Best Income Stocks to Buy for April 12th
by Zacks Equity Research
GRIN, FNF, and PTR made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 12, 2022.
Here's Why You Should Stay Invested in Old Republic (ORI)
by Zacks Equity Research
Old Republic International Corporation (ORI) is poised for growth on solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and robust capital position.
FNF Group (FNF) Loses 8.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
FNF Group (FNF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Top 5 Insurance Stocks to Play Soaring U.S. Bond Yields
by Nalak Das
We have narrowed our search to five large-cap insurers that saw positive earnings estimate revisions within the last 60 days. These are: ACGL, AFG, CINF, FNF and TRV.
Here's Why You Should Stay Invested in Brown & Brown (BRO)
by Zacks Equity Research
Segmental outperformance, strategic buyouts and a solid financial position well poise Brown & Brown (BRO) for growth.
Here's Why You Should Stay Invested in Voya Financial (VOYA)
by Zacks Equity Research
Voya Financial Inc. (VOYA) is poised for growth, given solid performance across Wealth Solutions, Investment Management and Health Solutions.
Best Value Stocks to Buy for April 7th
by Zacks Equity Research
WLK, FNF, and SUN made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 7, 2022.